Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,267 | 6,369 | 2,356 | 3,555 | 6,518 |
| Receivables | 2,202 | 2,093 | 2,265 | 1,865 | 1,638 |
| TOTAL | $8,144 | $9,065 | $5,511 | $6,972 | $8,684 |
| Non-Current Assets | |||||
| PPE Net | 1,079 | 1,146 | 1,210 | 1,471 | 1,541 |
| Other Non-Current Assets | 1,981 | 2,117 | 2,164 | 2,064 | 2,665 |
| TOTAL | $3,060 | $3,263 | $3,374 | $3,535 | $4,206 |
| Total Assets | $11,204 | $12,328 | $8,885 | $10,507 | $12,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,347 | 4,729 | 6,415 | 4,911 | 3,095 |
| Other current liabilities | 213 | 240 | 237 | 236 | 227 |
| TOTAL | $70,798 | $72,549 | $75,559 | $5,431 | $10,409 |
| Non-Current Liabilities | |||||
| Long Term Debt | 781 | 781 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,952 | 1,861 | 2,001 | 79,532 | 73,101 |
| TOTAL | $2,733 | $2,642 | $2,001 | $79,532 | $73,101 |
| Total Liabilities | $73,531 | $75,191 | $77,560 | $84,963 | $83,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,534 | 4,529 | 4,110 | 3,168 | 2,076 |
| Common Shares | 7 | 7 | 6 | N/A | 3 |
| Retained earnings | -253,618 | -250,609 | -251,468 | -245,714 | -239,677 |
| TOTAL | $-62,327 | $-62,863 | $-68,675 | $-74,456 | $-70,620 |
| Total Liabilities And Equity | $11,204 | $12,328 | $8,885 | $10,507 | $12,890 |